Jury Awards Damages for Edgeworth Client in Patent Infringement Suit

An Edgeworth Economics client, Royal DSM, a Netherlands-based biotechnology firm, was awarded damages in a patent infringement matter before the United States District Court for the Western District of Wisconsin. Defendants were accused of infringing DSM’s patent—which relates to strains of genetically-modified yeast used in the production of bioethanol—through the sale of their yeast products known as TransFerm Yield+ and YP3.

Edgeworth Partner Dr. Jesse David testified at trial regarding a reasonable royalty owed to DSM as a result of the alleged infringement. The jury determined that DSM’s valid patent had been infringed and awarded damages of $14.5 million.


Jump to Page

This website uses cookies to improve functionality and performance. By continuing to use this website, you agree to the use of cookies in accordance with our Privacy Policy.  If you are a California resident, read our California Information Practices.